Instrument | ||||
---|---|---|---|---|
14/11/2023 | CH1111025669 | Notice to Investors of JB Tracker Certificate on the European Dividend Stars Basket VIII Valor / ISIN / Symbol 111102566 / CH1111025669 / DAJBJB | Corporate Action | |
07/11/2023 | CH0359145411 | Notice to Investors of JB Actively Managed Certificate on the DW Global Resource Efficiency Index Valor / ISIN / Symbol 35914541 / CH0359145411 / DAFZJB | Corporate Action | |
04/10/2023 | CH1286512434 | Notice to Investors of Range Accrual Warrants on Novartis Inc Valor / ISIN / Symbol 128651243 / CH1286512434 / RNAHJB | Corporate Action | |
04/10/2023 | CH1284848822 | Notice to Investors of 6.00% p.a. JB Callable Barrier Reverse Convertible (80%) on Novartis AG Valor / ISIN / Symbol 128484882 / CH1284848822 / SAEIJB | Corporate Action | |
04/10/2023 | CH1282670574 | Notice to Investors of 9.50% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Roche Holding AG, Nestle SA, Novartis AG, Zurich Insurance Group AG Valor / ISIN / Symbol 128267057 / CH1282670574 / MANHJB | Corporate Action | |
04/10/2023 | CH1282670566 | Notice to Investors of 8.00% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Roche Holding AG, Nestle SA, Novartis AG, Zurich Insurance Group AG Valor / ISIN / Symbol 128267056 / CH1282670566 / MANGJB | Corporate Action | |
04/10/2023 | CH1282670558 | Notice to Investors of 6.50% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Roche Holding AG, Nestle SA, Novartis AG, Zurich Insurance Group AG Valor / ISIN / Symbol 128267055 / CH1282670558 / MANEJB | Corporate Action | |
04/10/2023 | CH1276583890 | Notice to Investors of 6.65% p.a. JB Barrier Reverse Convertible (85%) on Novartis AG Valor / ISIN / Symbol 127658389 / CH1276583890 / SBPMJB | Corporate Action | |
04/10/2023 | CH1259763089 | Notice to Investors of 6.90% p.a. JB Callable Barrier Reverse Convertible (80%) on Novartis AG Valor / ISIN / Symbol 125976308 / CH1259763089 / SAUZJB | Corporate Action | |
04/10/2023 | CH1259713324 | Notice to Investors of Call Warrants on Novartis Inc Valor / ISIN / Symbol 125971332 / CH1259713324 / NOVQJB | Corporate Action | |
04/10/2023 | CH1255584349 | Notice to Investors of JB Capped Bonus Certificate on Novartis AG Valor / ISIN / Symbol 125558434 / CH1255584349 / SALWJB | Corporate Action | |
04/10/2023 | CH1255577988 | Notice to Investors of 7.00% p.a. JB Callable Multi Barrier Reverse Convertible (55%) on Lonza Group AG, Novartis AG, Roche Holding AG Valor / ISIN / Symbol 125557798 / CH1255577988 / MBJEJB | Corporate Action | |
04/10/2023 | CH1250039281 | Notice to Investors of JB Bonus Certificate on Novartis AG Valor / ISIN / Symbol 125003928 / CH1250039281 / SBOJJB | Corporate Action | |
04/10/2023 | CH1250039232 | Notice to Investors of 6.25% p.a. JB Callable Barrier Reverse Convertible (85%) on Novartis AG Valor / ISIN / Symbol 125003923 / CH1250039232 / SBOEJB | Corporate Action | |
04/10/2023 | CH1250039158 | Notice to Investors of 6.40% p.a. JB Barrier Reverse Convertible (85%) on Novartis AG Valor / ISIN / Symbol 125003915 / CH1250039158 / SBNWJB | Corporate Action | |
04/10/2023 | CH1250038531 | Notice to Investors of 7.50% p.a. JB Barrier Reverse Convertible (90%) on Novartis AG Valor / ISIN / Symbol 125003853 / CH1250038531 / SBNFJB | Corporate Action | |
04/10/2023 | CH1243066656 | Notice to Investors of JB 1Y CHF 98% Capital Protection Note with Participation on Nestle SA, Novartis AG, Roche Holding AG Valor / ISIN / Symbol 124306665 / CH1243066656 / MBHSJB | Corporate Action | |
04/10/2023 | CH1239729184 | Notice to Investors of JB Bonus Certificate on Novartis AG Valor / ISIN / Symbol 123972918 / CH1239729184 / SBKEJB | Corporate Action | |
04/10/2023 | CH1239728335 | Notice to Investors of 7.75% p.a. JB Barrier Reverse Convertible (90%) on Novartis AG Valor / ISIN / Symbol 123972833 / CH1239728335 / SACYJB | Corporate Action | |
04/10/2023 | CH1229751057 | Notice to Investors of 6.50% p.a. JB Callable Multi Barrier Reverse Convertible (60%) on Nestle SA, Roche Holding AG, Novartis AG Valor / ISIN / Symbol 122975105 / CH1229751057 / MAZHJB | Corporate Action |